Comparative efficacy and safety of first-line treatments for advanced non-small cell lung cancer with ALK-rearranged: a meta-analysis of clinical trials

Overview of attention for article published in BMC Cancer, November 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter: 1 X user

Readers on

mendeley: 31 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 2,454 followers.

Comparative efficacy and safety of first-line treatments for advanced non-small cell lung cancer with ALK-rearranged: a meta-analysis of clinical trials #lymphoma #lymsm https://t.co/8kRBmGgqYa

28 Nov 2021

Reply Repost Favourite

Comparative efficacy and safety of first-line treatments for advanced non-small cell lung cancer with ALK-rearranged: a meta-analysis of clinical trials #lymphoma #lymsm https://t.co/FeZXHX94rZ

27 Nov 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.